Home > PJ (current issue) > Letters | Search

PJ Online homeThe Pharmaceutical Journal
Vol 280 No 7497 p438
12 April 2008

This article
Reprint   Photocopy

PDF 60K, Acrobat Reader

Letters

• White paper
• Community pharmacy
• Domain names
• Minor ailment scheme
• Electronic prescriptions
• Hospital pharmacy
• Procurement
• Euthanasia
• Council election
• Health and safety
• The Society (2)


Letters to the Editor

Procurement

Instant magnesium sulphate infusion bags

From Mr U. M. Chouhan, MRPharmS

Magnesium sulphate infusion has many therapeutic indications, including arrhythmia, hypomagnesaemia and eclampsia. However, when it comes to prescribing the drug the doses are expressed differently. For arrhythmia, the British National Formulary (number 54) states the dose in millimoles while for prevention of seizures in eclampsia the dose is given in grams.

The matter is further complicated because the ampoules are labelled as a percentage of magnesium sulphate. Consequently, it is not surprising that errors in calculation occur. In addition, preparation of infusions in clinical areas is a major contributor in incorrect dosing as exemplified by preparation of opiates and acetylcysteine.

The National Patient Safety Agency patient safety alert 20 issued in March 2007 recommends that a risk assessment of each injectable product be done together with the clinical area it is prepared in. Based on the risk assessment, the Welsh Aseptic Services and Production Pharmacists Group gave a high score for magnesium sulphate, suggesting there is a high risk that it could cause harm.

To overcome the problem, the pharmacy at Glan Clwyd Hospital has provided ready-to-use intravenous infusion bags since 2004, containing 80mmol (20g) of magnesium sulphate in 250ml sodium chloride 0.9 per cent. The bags are produced commercially and have a shelf-life of 18 months. Our commitment is to purchase the whole batch over the 18 months. However, due to increased production costs the price of the next batch will more than double.

The cost of each bag can be reduced by increasing the batch size. Our current usage level means the whole batch cannot be used within its shelf-life. At a batch size of 2,960 bags, the cost per bag would be £2.95 plus VAT. Glan Clwyd Hospital would use about 1,000 bags per year.

If there is a trust that would be interested in committing to purchase the balance of the prepared batch directly from the company, it can contact me at uttam.chouhan@cd-tr.wales.nhs.uk

Uttam M. Chouhan
Principal Pharmacist (Clinical Services),
Glan Clwyd Hospital,
Rhyl, Denbighshire

Send your letter to The Editor

Previous Topic (Hospital pharmacy)
Next Topic (Euthanasia)

Back to Top


©The Pharmaceutical Journal